Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,609 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,034
Recruiting: 591
Ph III recruiting: 61
Growth YoY: +8.6%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (799)

clinicaltrialsPublishedShowing 301–311 of 311 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03825796	CPX-351 Plus Enasidenib for Relapsed AML	active not recruiting	Phase 2	2	Jonsson Comprehensive Cancer CenterOTHER	1	Sep 28, 2023	clinicaltrials
NCT05515029	Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis	active not recruiting	Phase 3	56	Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER	1	Sep 28, 2023